Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beware the Medical-Industrial Complex.

Stevens1, Glatstein

  • 1Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.

The Oncologist
|January 1, 1996
PubMed
Summary

The corporatization of healthcare prioritizes profit over innovation, hindering medical research and patient outcomes. True progress requires focusing on biological understanding and cost-effective, evidence-based cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019
Same author

Uncompensated resistance. 2. The effect of reference electrode nonideality

Analytical chemistry·2000
Same author

Measurement of structure-dependent K+ --> &mgr;(+)nu(&mgr;)gamma decay

Physical review letters·2000
Same author

Computer-aided design and experimental investigation of a hydrodynamic device: the microwire electrode

Analytical chemistry·2000
Same author

Transmission Electron Diffraction at 200 eV and Damage Thresholds below the Carbon K Edge.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2000
Same author

Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family.

European journal of human genetics : EJHG·2000

Area of Science:

  • Oncology
  • Health Policy
  • Biotechnology

Background:

  • The corporatization of healthcare in the U.S. is shifting focus from medical advancement to financial outcomes.
  • Physicians face pressure to justify treatment decisions based on cost, impacting innovation and research.
  • Technological advancements in cancer treatment often lack clear biological advantages, prioritizing efficiency and profit.

Purpose of the Study:

  • To analyze the impact of corporate influence and financial pressures on medical innovation and patient care in oncology.
  • To advocate for a shift towards prioritizing biological understanding and evidence-based treatments over cost-driven decisions.
  • To propose strategies for academic medical centers to adapt and thrive amidst managed care pressures.

Main Methods:

  • Critical analysis of current trends in cancer treatment technology and their purported benefits versus actual clinical impact.
  • Review of the economic pressures on academic medical centers and their implications for research and patient access.
  • Discussion of historical perspectives on medical progress and the challenges posed by corporate interests.

Main Results:

  • Many new cancer technologies offer marginal clinical benefits despite high costs, driven by marketing and profit motives.
  • Current radiation therapy technologies have likely reached optimal parameters, with limited gains from newer, expensive modalities.
  • Understanding cancer cell biology and developing targeted therapies, potentially through gene therapy or drug interventions, remains the key challenge.

Conclusions:

  • A balanced approach is needed, integrating technological advancements with a deep understanding of cancer biology.
  • Academic medical centers must reform by fostering community partnerships, optimizing efficiency, and investing wisely in impactful technologies.
  • Prioritizing cost over evidence-based outcomes risks stifling research and compromising patient care, necessitating a focus on value and public good.

Related Experiment Videos